View Future GrowthPaltac 過去の業績過去 基準チェック /16Paltacの収益は年間平均-3.6%の割合で減少していますが、 Retail Distributors業界の収益は年間 減少しています。収益は年間11.8% 4.2%割合で 増加しています。 Paltacの自己資本利益率は7.3%であり、純利益率は1.8%です。主要情報-3.64%収益成長率-2.04%EPS成長率Retail Distributors 業界の成長20.65%収益成長率4.19%株主資本利益率7.30%ネット・マージン1.78%次回の業績アップデート03 Aug 2026最近の業績更新お知らせ • Jun 09Paltac Corporation to Report Q1, 2027 Results on Aug 03, 2026Paltac Corporation announced that they will report Q1, 2027 results on Aug 03, 2026お知らせ • May 10Paltac Corporation to Report Fiscal Year 2026 Results on May 11, 2026Paltac Corporation announced that they will report fiscal year 2026 results on May 11, 2026お知らせ • Dec 02Paltac Corporation to Report Q3, 2026 Results on Feb 06, 2026Paltac Corporation announced that they will report Q3, 2026 results on Feb 06, 2026お知らせ • Sep 02Paltac Corporation to Report Q2, 2026 Results on Nov 04, 2025Paltac Corporation announced that they will report Q2, 2026 results on Nov 04, 2025すべての更新を表示Recent updatesお知らせ • Jul 14Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)お知らせ • Jul 08MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. As of June 19, 2026, S.T. Corporation has resolved to tender its 339,000 shares. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation. MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders on July 7, 2026. A total of 24,466,104 shares were tendered, which was above the minimum number of shares to be purchased (8,676,100 shares). MediPal Holdings Corporation plans to implement a series of procedures to make the Tender Offeror the sole shareholder of Paltac Corporation (the “Squeeze-out Procedures”). Upon completion, the shares of Paltac Corporation will be delisted from the Prime Market of the Tokyo Stock Exchange.お知らせ • Jun 19Paltac Corporation Announces Management ChangesPaltac Corporation announced that, at a meeting of the Board of Directors held on June 19, 2026, it resolved to make changes in its directors and executive officers. Masahiro Noma was redesignated from Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters to Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters, General Manager of Logistics Headquarters. Masashi Gotan retired from the position of Executive Officer, General Manager of Logistics Headquarters and was attached to the General Affairs Headquarters.お知らせ • Jun 09Paltac Corporation to Report Q1, 2027 Results on Aug 03, 2026Paltac Corporation announced that they will report Q1, 2027 results on Aug 03, 2026お知らせ • May 12MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation.お知らせ • May 11Paltac Corporation, Annual General Meeting, Jun 19, 2026Paltac Corporation, Annual General Meeting, Jun 19, 2026.お知らせ • May 10Paltac Corporation to Report Fiscal Year 2026 Results on May 11, 2026Paltac Corporation announced that they will report fiscal year 2026 results on May 11, 2026お知らせ • Dec 02Paltac Corporation to Report Q3, 2026 Results on Feb 06, 2026Paltac Corporation announced that they will report Q3, 2026 results on Feb 06, 2026お知らせ • Sep 02Paltac Corporation to Report Q2, 2026 Results on Nov 04, 2025Paltac Corporation announced that they will report Q2, 2026 results on Nov 04, 2025収支内訳Paltac の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:PCCO.F 収益、費用、利益 ( )JPY Millions日付収益収益G+A経費研究開発費31 Mar 261,237,84622,03165,922031 Dec 251,227,66921,90264,922030 Sep 251,212,80522,10563,520030 Jun 251,201,23023,02862,231031 Mar 251,188,09722,86461,088031 Dec 241,179,98821,77660,468031 Mar 241,151,96620,63859,2170質の高い収益: PCCO.Fは 高品質の収益 を持っています。利益率の向上: PCCO.Fの現在の純利益率 (1.8%)は、昨年(1.9%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: PCCO.Fの過去 5 年間の前年比収益成長率がプラスであったかどうかを判断するにはデータが不十分です。成長の加速: PCCO.Fは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: PCCO.Fは過去 1 年間で収益成長率がマイナス ( -3.6% ) となったため、 Retail Distributors業界平均 ( -19% ) と比較することが困難です。株主資本利益率高いROE: PCCO.Fの 自己資本利益率 ( 7.3% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YRetail 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/23 20:12終値2026/05/11 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Paltac Corporation 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。4 アナリスト機関Oliver James Gray MatthewCLSAYumiko KaiIchiyoshi Research Institute Inc.Kyoichiro ShigemuraNomura Securities Co. Ltd.1 その他のアナリストを表示
お知らせ • Jun 09Paltac Corporation to Report Q1, 2027 Results on Aug 03, 2026Paltac Corporation announced that they will report Q1, 2027 results on Aug 03, 2026
お知らせ • May 10Paltac Corporation to Report Fiscal Year 2026 Results on May 11, 2026Paltac Corporation announced that they will report fiscal year 2026 results on May 11, 2026
お知らせ • Dec 02Paltac Corporation to Report Q3, 2026 Results on Feb 06, 2026Paltac Corporation announced that they will report Q3, 2026 results on Feb 06, 2026
お知らせ • Sep 02Paltac Corporation to Report Q2, 2026 Results on Nov 04, 2025Paltac Corporation announced that they will report Q2, 2026 results on Nov 04, 2025
お知らせ • Jul 14Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)Paltac Corporation(TSE:8283) dropped from FTSE All-World Index (USD)
お知らせ • Jul 08MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. As of June 19, 2026, S.T. Corporation has resolved to tender its 339,000 shares. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation. MediPal Holdings Corporation (TSE:7459) completed the acquisition of remaining 47.60% stake in Paltac Corporation (TSE:8283) from group of shareholders on July 7, 2026. A total of 24,466,104 shares were tendered, which was above the minimum number of shares to be purchased (8,676,100 shares). MediPal Holdings Corporation plans to implement a series of procedures to make the Tender Offeror the sole shareholder of Paltac Corporation (the “Squeeze-out Procedures”). Upon completion, the shares of Paltac Corporation will be delisted from the Prime Market of the Tokyo Stock Exchange.
お知らせ • Jun 19Paltac Corporation Announces Management ChangesPaltac Corporation announced that, at a meeting of the Board of Directors held on June 19, 2026, it resolved to make changes in its directors and executive officers. Masahiro Noma was redesignated from Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters to Director, Senior Managing Executive Officer, Senior General Manager of Administration Headquarters, General Manager of Logistics Headquarters. Masashi Gotan retired from the position of Executive Officer, General Manager of Logistics Headquarters and was attached to the General Affairs Headquarters.
お知らせ • Jun 09Paltac Corporation to Report Q1, 2027 Results on Aug 03, 2026Paltac Corporation announced that they will report Q1, 2027 results on Aug 03, 2026
お知らせ • May 12MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion.MediPal Holdings Corporation (TSE:7459) proposed to acquire remaining 47.60% stake in Paltac Corporation (TSE:8283) from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. (AVFC) RE FIDELITY FUNDS for approximately ¥190 billion on May 8, 2026. A cash consideration of ¥192.46 billion valued at ¥6650 per share will be paid by MediPal Holdings Corporation. As part of consideration, ¥192.46 billion is paid towards common equity of Paltac Corporation. Upon completion, MediPal Holdings Corporation will hold 100% stake of Paltac Corporation. The transaction will be funded by means of loans from Mizuho Bank, Ltd. The transaction is subject to minimum tender. The Board of Directors of Paltac Corporation formed a special committee for the transaction. The expected completion of the transaction is on July 7, 2026. Nishimura & Asahi acted as legal advisor for MediPal Holdings Corporation. Nomura Securities Co., Ltd. acted as financial advisor for MediPal Holdings Corporation. Oh-Ebashi LPC & Partners acted as legal advisor for Paltac Corporation. Daiwa Securities Co. Ltd. acted as financial advisor for Paltac Corporation. Anderson Mori & Tomotsune acted as legal advisor for Paltac Corporation. Plutus Consulting Co., Ltd. acted as financial advisor and fairness opinion provider for Paltac Corporation.
お知らせ • May 11Paltac Corporation, Annual General Meeting, Jun 19, 2026Paltac Corporation, Annual General Meeting, Jun 19, 2026.
お知らせ • May 10Paltac Corporation to Report Fiscal Year 2026 Results on May 11, 2026Paltac Corporation announced that they will report fiscal year 2026 results on May 11, 2026
お知らせ • Dec 02Paltac Corporation to Report Q3, 2026 Results on Feb 06, 2026Paltac Corporation announced that they will report Q3, 2026 results on Feb 06, 2026
お知らせ • Sep 02Paltac Corporation to Report Q2, 2026 Results on Nov 04, 2025Paltac Corporation announced that they will report Q2, 2026 results on Nov 04, 2025